Google co-founder
- Catalyst4, a non-profit investment vehicle set up using the proceeds of Brin’s 2021 sale of his Tesla stake, will cover around $15m of a $25m funding round
- Round set to close after summer
- Soneira is launching clinical trials looking at the use of hallucinogen ibogaine as a treatment for traumatic brain injury
- Soneira declined to comment to the FT; Catalyst4 did not respond
- NOTE: In April,
Brin-Backed Startup Nears Firing Up First Carbon Removal Machine
To view ...
Learn more about Bloomberg Law or Log In to keep reading:
See Breaking News in Context
Bloomberg Law provides trusted coverage of current events enhanced with legal analysis.
Already a subscriber?
Log in to keep reading or access research tools and resources.
